MPO and coronary artery disorder: Further research is necessary to understand why low-HDL CAD subjects appear vulnerable to MPO-mediated oxidative damage and to uncover alternate mechanisms by which, despite unchanged MPO levels, MPO oxidizes HDL in the low-HDL CAD cohort.